maybe but you've just given up 30% of any win to sage and co (shares plus oppies) so all you've done is swap a funder at 30-40% for dilution at 30% - not exactly a huge win for shareholders. the scary thing remains, what deals and liabilities hasn't the board told shareholders about?
